Inhaltsbereich
| 9 Einträge |
Seite 1 / 1
 Druckansicht
|
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
| Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| PMID: 29146401 |
| Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial. |
| Narula N, Wong ECL, Aruljothy A, Dulai PS, Colombel JF, Marshall JK, Ferrante M, Reinisch W |
| The American journal of gastroenterology. doi: 10.14309/ajg.0000000000000617. pii: 00000434-202008000-00022 |
| PMID: 32759621 |
| Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for One-Year Endoscopic Remission in Moderate to Severe Crohn's Disease. |
| Narula N, Wong ECL, Colombel JF, Sandborn WJ, Ferrante M, Marshall JK, Reinisch W, Dulai PS |
| Journal of Crohn's & colitis. 2021 Oct 19. pii: 6401649. doi: 10.1093/ecco-jcc/jjab183 |
| PMID: 34664635 |
| Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab. |
| Dulai PS, Wong ECL, Reinisch W, Colombel JF, Marshall JK, Narula N |
| Inflammatory bowel diseases. 2021 Dec 30. pii: 6490022. doi: 10.1093/ibd/izab310 |
| PMID: 34967397 |
| Categorizing Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD (MM-SES-CD). |
| Narula N, Pray C, Wong ECL, Colombel JF, Marshall JK, Daperno M, Reinisch W, Dulai PS |
| Journal of Crohn's & colitis. 2022 Feb 3. pii: 6520897. doi: 10.1093/ecco-jcc/jjac018 |
| PMID: 35134140 |
| Resolution of dominant patient-reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's disease. |
| Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N |
| Alimentary pharmacology & therapeutics. 2022 Feb 15. doi: 10.1111/apt.16805 |
| PMID: 35166396 |
| Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply. |
| Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N |
| Alimentary pharmacology & therapeutics. doi: 10.1111/apt.16866 |
| PMID: 35362140 |
| Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease. |
| Narula N, Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W |
| The American journal of gastroenterology. 2022 Apr 15. doi: 10.14309/ajg.0000000000001795. pii: 00000434-990000000-00336 |
| PMID: 35435862 |
| Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19. |
| Einstein AJ, Hirschfeld C, Williams MC, Vitola JV, Better N, Villines TC, Cerci R, Shaw LJ, Choi AD, Dorbala S, Karthikeyan G, Lu B, Sinitsyn V, Ansheles AA, Kudo T, Bucciarelli-Ducci C, Nørgaard BL, Maurovich-Horvat P, Campisi R, Milan E, Louw L, Allam AH, Bhatia M, Sewanan L, Malkovskiy E, Cohen Y, Randazzo M, Narula J, Morozova O, Pascual TNB, Pynda Y, Dondi M, Paez D |
| Journal of the American College of Cardiology. pii: S0735-1097(22)04561-2. doi: 10.1016/j.jacc.2022.03.348 |
| PMID: 35589162 |
| 9 Einträge |
Seite 1 / 1
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
